Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.385 USD | -0.36% | +2.21% | +17.94% |
05-13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
05-09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.94% | 104M | |
+8.59% | 115B | |
+9.41% | 105B | |
-12.26% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.74% | 16.01B | |
+1.85% | 14.14B | |
+20.19% | 10.71B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Insider Trends: Insider Buying Prolonged with Purchase of Clearside Biomedical Shares